Account

Meet your next launch strategy partner

Remap Consulting is the pricing and market access launch partner to help you launch with confidence.

How we can support you:
Pricing & Reimbursement Launch Strategy
Joint Clinical Assessment
Joint Scientific Consultation
HTA/Payer Early Dialogue
Payer Value Communication Strategy
Launch Implementation

We can help you

  • Develop and implement a pricing and market access launch strategy for your product
  • Provide pricing and market access launch expertise to global, regional and local teams
  • Prepare, file and co-ordinate country specific HTA / pricing and reimbursement submissions
  • Obtain early payer scientific advice to integrate payer insights into your clinical development program
  • Develop an evidence-based value proposition that resonates with payers

Discover the latest insights

WODC Europe 2024: Are NICE Achieving Their Timelin…
AUTHORS: Amrit Kaliasethi, Tia Kwong, Mariam Bibi OBJECTIVES  In 2013, England’s National Ins…
Read more
WODC Europe 2024: Comparing And Contrasting Early …
AUTHORS: Amy Boyers, Solen Monteil, Mariam Bibi OBJECTIVES  Early Access Programmes (EAPs) prov…
Read more
market access
How to integrate Market Access strategy with evide…
Introduction What is the secret to a successful drug launch? One crucial factor is establishing a cr…
Read more
EU HTA process
ISPOR Europe 2024: Can Patient Involvement Help Op…
We explore whether including the patient voice in early stages of drug development optimises patient…
Read more
market access
Adapting to the EU HTA: how to restructure your Ma…
Our latest article discusses key strategies for pharma manufacturers’ commercial readiness for EU HT…
Read more
market access
What does the right market access organisation str…
Effective pricing and market access (PMA) teams are vital for pharmaceutical companies to secure rei…
Read more
UK
Scotland leads the UK in approving Mounjaro for ob…
Scottish Medicines Consortium approves the use of obesity treatment under the NHS in UK first, whils…
Read more
Securing the optimum launch price for a novel phar…
Looking to enhance your market access capabilities? Remap Consulting are the partner to help you lau…
Read more
World EPA Congress 2024
The World Evidence, Pricing, and Access (EPA) Congress stands as Europe’s premier event in mar…
Read more
market access
Is the attractiveness of launch in the UK changing…
This expert article focusses on the new proportionate approach, and the international recognition pr…
Read more

I really enjoyed working with Remap Consulting and received powerful advice. A small company like ours needs to receive a flexible approach in order start with market access activities, and I am very happy to see you are as flexible as possible with us.

Director of Market Access
Small pharma payer insights for clinical trials

Remap Consulting’s pricing knowledge and support has been critical to the success of our new pricing team. Their combined experience has provided them with ‘real-world‘ knowledge that can support their recommendations. I highly recommend Remap Consulting and am delighted to continue my work with their pricing group.

Senior Director, Head of Global Pricing
Outsourcing pricing activities for large biotech

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.

Talk to an expert

Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.​

Get in touch